Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Placebo-Controlled Double-Blind Study to Evaluate the Efficacy and Safety of Asacol™ 4.8 g/Day (800 mg Tablets) for the Treatment of Active Ulcerative Colitis

NCT01059344 is registered in ClinicalTrials.gov with Tillotts Pharma AG as lead sponsor.

NCT NCT01059344
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01059344 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Placebo-Controlled Double-Blind Study to Evaluate the Efficacy and Safety of Asacol™ 4.8 g/Day (800 mg Tablets) for the Treatment of Active Ulcerative Colitis
Lead sponsor
Tillotts Pharma AG
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2009
Completion date
August 31, 2011
Enrollment
281 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis